Tumor reduction by a small molecule human PD-1/PD-L1 inhibitor in a melanoma/PBMC co-implantation model.

被引：0

作者：

Vilalta, Marta ^{[1
]}

Punna, Sreenivas ^{[1
]}

Li, Shijie Chris ^{[1
]}

Malathong, Viengkham ^{[1
]}

Lange, Christopher ^{[1
]}

McMurtrie, Darren ^{[1
]}

Yang, Ju ^{[1
]}

Roth, Howard ^{[1
]}

McMahon, Jeffrey ^{[1
]}

Campbell, James J. ^{[1
]}

Ertl, Linda S. ^{[1
]}

Ong, Ryan ^{[1
]}

Wang, Yu ^{[1
]}

Zhao, Niky ^{[1
]}

Chhina, Vicky ^{[1
]}

Kumamoto, Alice ^{[1
]}

Yau, Simon ^{[1
]}

Dang, Tong ^{[1
]}

Zhang, Penglie ^{[1
]}

Schall, Thomas J. ^{[1
]}

Singh, Rajinder ^{[1
]}

机构：

[1] ChemoCentryx, Mountain View, CA USA

来源：

CANCER IMMUNOLOGY RESEARCH | 2020年 / 8卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B26

引用

页码：95 / 95

页数：1

共 50 条

[21] In vitro assay for the development of small molecule inhibitors targeting PD-1/PD-L1
Zhai, Wenjie
Zhou, Xiuman
Du, Jiangfeng
Gao, Yanfeng
TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - MOLECULAR METHODS, 2019, 629 : 361 - 381
[22] Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization
Guo, Yan
Jin, Yulong
Wang, Bingfeng
Liu, Boping
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
[23] The PD-1/PD-L1 Pathway in Human Pathology
Saresella, M.
Rainone, V.
Al-Daghri, N. M.
Clerici, M.
Trabattoni, D.
CURRENT MOLECULAR MEDICINE, 2012, 12 (03) : 259 - 267
[24] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
Lilo, Mohammed
Berry, Sneha
Xu, Haiying
Ogurtsova, Aleksandra
Lipson, Evan
Taube, Janis
MODERN PATHOLOGY, 2015, 28 : 123A - 123A
[25] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
Lilo, Mohammed
Berry, Sneha
Xu, Haiying
Ogurtsova, Aleksandra
Lipson, Evan
Taube, Janis
LABORATORY INVESTIGATION, 2015, 95 : 123A - 123A
[26] Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
Salehi, Shima
Ghaderi, Hajarossadat
Habibi-Anbouhi, Mahdi
Shoari, Alireza
Eskafi, Ayda Hassanzadeh
Sabouri, Alireza
Hosseininejad-Chafi, Mohammad
Ardalan, Arghavan Ashja
Ramezani, Behzad
Kazemi-Lomedasht, Fatemeh
Behdani, Mahdi
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01):
[27] PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study
Chen, Mifen
Wang, Zhenghang
Liu, Zimin
Deng, Ting
Wang, Xiaodong
Chang, Zhiwei
Zhang, Qi
Yang, Wenlei
Liu, Ning
Ji, Zhi
Zhang, Xiaotian
Wang, Xicheng
Peng, Zhi
Li, Yi
Cao, Yujuan
Jin, Xuan
Lu, Hongxia
Qu, Huajun
Tang, Yong
Xu, Chunlei
Fang, Weijia
Zhang, Hangyu
Yan, Dong
Wang, Li
Li, Jiayi
Zhang, Jingdong
Wang, Qiwei
Xue, Liying
Yin, Fei
Han, Guangjie
Cheng, Zhiqiang
Liu, Qing
Jin, Yongdong
Zhang, Yinjie
Li, Lanxing
Cao, Baoshan
Yao, Yanhong
Chen, Zhiyu
Zou, Jianling
Ying, Jieer
Wei, Qing
Tian, Tiantian
Zhao, Weifeng
Li, Longmei
Zhang, Tong
Song, Fanghua
Ba, Ya-er
Li, Na
Gao, Hui
Ji, Yinghua
JCO PRECISION ONCOLOGY, 2023, 7
[28] PD-1, PD-L1, and PD-L2 Gene Expression and Tumor Infiltrating Lymphocytes in Canine Melanoma
Stevenson, Valentina B.
Perry, Samantha N.
Todd, Michelle
Huckle, William R.
LeRoith, Tanya
VETERINARY PATHOLOGY, 2021, 58 (04) : 692 - 698
[29] Identification of the FDA-Approved Drug Pyrvinium as a Small-Molecule Inhibitor of the PD-1/PD-L1 Interaction
Fattakhova, Elena
Hofer, Jeremy
DiFlumeri, Juliette
Cobb, Madison
Dando, Timothy
Romisher, Zachary
Wellington, Justin
Oravic, Michael
Radnoff, Madison
Patil, Sachin P.
CHEMMEDCHEM, 2021, 16 (18) : 2769 - 2774
[30] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Liu, Jinhua
Chen, Zichao
Li, Yaqun
Zhao, Wenjie
Wu, JiBiao
Zhang, Zhen
FRONTIERS IN PHARMACOLOGY, 2021, 12

← 1 2 3 4 5 →